Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia.
about
Brain Injury in the Preterm Infant: New Horizons for Pathogenesis and PreventionCerebral white and gray matter injury in newborns: new insights into pathophysiology and managementTGFbeta1 stimulates the over-production of white matter astrocytes from precursors of the "brain marrow" in a rodent model of neonatal encephalopathyDelayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4Transplanted glial restricted precursor cells improve neurobehavioral and neuropathological outcomes in a mouse model of neonatal white matter injury despite limited cell survival.Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.Pathophysiology of glia in perinatal white matter injury.Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges.The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined.Imaging selective vulnerability in the developing nervous system.Nitrosative stress and inducible nitric oxide synthase expression in periventricular leukomalacia.The cerebral cortex overlying periventricular leukomalacia: analysis of pyramidal neuronsThe encephalopathy of prematurity: one pediatric neuropathologist's perspective.The challenge of understanding cerebral white matter injury in the premature infant.Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelinationDaam2-PIP5K is a regulatory pathway for Wnt signaling and therapeutic target for remyelination in the CNSAltered glutamatergic metabolism associated with punctate white matter lesions in preterm infantsThe developing oligodendrocyte: key cellular target in brain injury in the premature infantUnmyelinated white matter loss in the preterm brain is associated with early increased levels of end-tidal carbon monoxide.Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination.Bone morphogenetic protein inhibition promotes neurological recovery after intraventricular hemorrhage.The biological basis of injury and neuroprotection in the fetal and neonatal brain.In vivo magnetization transfer MRI shows dysmyelination in an ischemic mouse model of periventricular leukomalacia.Abbreviated exposure to hypoxia is sufficient to induce CNS dysmyelination, modulate spinal motor neuron composition, and impair motor development in neonatal miceArrested preoligodendrocyte maturation contributes to myelination failure in premature infants.Potential neuronal repair in cerebral white matter injury in the human neonateNeuron deficit in the white matter and subplate in periventricular leukomalacia.Evidence that nuclear factor IA inhibits repair after white matter injuryThe role of inflammation in perinatal brain injury.White matter injury in the preterm infant: pathology and mechanisms.STAT3-mediated astrogliosis protects myelin development in neonatal brain injury.Oligodendrocyte regeneration after neonatal hypoxia requires FoxO1-mediated p27Kip1 expression.Neuroinflammation and structural injury of the fetal ovine brain following intra-amniotic Candida albicans exposure.Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytesCerebral inflammation and mobilization of the peripheral immune system following global hypoxia-ischemia in preterm sheepPossible relationship between common genetic variation and white matter development in a pilot study of preterm infantsSeparated at birth? The functional and molecular divergence of OLIG1 and OLIG2.Ischemia-induced neuroinflammation is associated with disrupted development of oligodendrocyte progenitors in a model of periventricular leukomalacia.Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances.Thalamic damage in periventricular leukomalacia: novel pathologic observations relevant to cognitive deficits in survivors of prematurity.
P2860
Q27009193-5C7C4CEC-C6B3-43C0-8B9C-42369895F0CEQ27022056-234AD947-14F7-4B24-8323-1D9EDF9A2ECCQ27333559-E7AEDFBB-91D2-4E66-9F05-F132D94A4A8FQ28582010-62C8CB67-1B4E-491F-ADBA-D5AB8CF12CD1Q30389642-025988CF-E7F7-484D-A4EF-345413DAB101Q30405077-D7EF0089-1740-42D5-B94A-D789A489E093Q30790294-85EB4E59-26D3-4AD2-AB48-5982377282C7Q30847961-8C144031-3E20-4071-98D3-151BDA541EB7Q33516828-C1561A7F-7A51-42FC-9E1C-42FA307F1162Q33561145-48E82334-3822-4F20-AC80-704B9706623EQ34015792-5C887070-F238-43DE-BC08-DD713B5DFD01Q34034819-8FC2A885-EA8F-4A3E-947D-161C8E6BD6B0Q34047382-074468EF-4A06-4FB3-B9D5-DC5363842247Q34098352-772F0485-5F02-4B70-A22E-EA143C6DFF83Q34253257-F47E2F12-61DF-4A1B-822B-59F35B787772Q34466406-F30BFB93-E7BF-41C9-8B9F-A8A95BCE77D2Q34611606-E186E5A6-5FFA-45EA-BDBF-53A972573949Q34995998-0903C040-C4BD-4782-ADBB-BC8647C48044Q35119052-A3688D38-C444-4F4B-9553-6A91CE412478Q35132066-811DDF1F-524B-4375-9622-66930D1BBE39Q35196642-CAD4955E-9FAD-4327-AB82-4932692B05BAQ35201430-761CE06E-3B3F-4CAB-A1D3-FE04E94A7D89Q35524122-53D7CF66-6B99-42E5-8FB7-22528584C50EQ35644564-A3B357C1-83F3-4544-852A-2DAD0480DBF2Q35727891-BEF701AA-FCF4-4771-9E3A-2F9CCFB8EDD6Q35767540-C99677FA-DF49-4D36-9CBB-C6BDE1AD9E6AQ35859815-3713B454-AB2B-4136-9CF1-BD79685338F6Q36194982-EB07832D-BFF3-41F6-A70A-8236D2D5E56CQ36331560-50D65882-03ED-4F57-B411-75FCAFD77D21Q36378391-38D27A0E-F333-4E89-A328-884F27AA7C8DQ36445816-9F5BF111-1372-4F8F-9312-5777BC3E373EQ36453502-D7DBE836-C24D-4D4D-8E56-C15FEDEFC791Q36538081-A92404F3-C8B2-46AB-9F12-A58284A674E5Q36631757-33ABC388-9A0A-4900-828F-3EEFBD553600Q36734811-3CABF742-AAC1-41C5-95FD-57A2FD73A8CEQ36768181-47D2D4B7-424B-4ACF-AB32-9F0750A273D9Q37069461-5A806C37-E8A5-4C07-AC13-7E120A7478D8Q37150480-5184CAFB-A7FF-4670-BE25-F126E7825331Q37253850-89899C8A-7A21-4544-845E-2037ABEFF8D3Q37269952-7E8F422B-1A27-4E1E-ABAD-15B0E64966C0
P2860
Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia.
@en
Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia.
@nl
type
label
Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia.
@en
Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia.
@nl
prefLabel
Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia.
@en
Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia.
@nl
P2093
P2860
P1433
P1476
Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia.
@en
P2093
David H Rowitch
Felicia L Trachtenberg
Hannah C Kinney
Joseph J Volpe
Keith L Ligon
Natalia S Borenstein
Rebecca D Folkerth
Robin L Haynes
Saraid S Billiards
P2860
P304
P356
10.1111/J.1750-3639.2007.00107.X
P577
2008-01-03T00:00:00Z